TruBridge, Inc. TBRG Financial Health — Product development
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by TruBridge, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.
The official record: TruBridge, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about TruBridge, Inc.'s financial health — product development.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is TruBridge, Inc.'s financial health — product development?
- TruBridge, Inc. (TBRG) reported financial health — product development of $3.06M in Q1 2026.
- How has TruBridge, Inc.'s financial health — product development changed year-over-year?
- TruBridge, Inc.'s financial health — product development decreased by 1.5% year-over-year, from $3.11M to $3.06M.
- What is the long-term trend for TruBridge, Inc.'s financial health — product development?
- Over 3 years (2022 to 2025), TruBridge, Inc.'s financial health — product development has grown at a 24.3% compound annual growth rate (CAGR), from $6.61M to $12.68M.
- What does financial health — product development mean?
- Measures the investment allocated to research, design, and engineering activities aimed at enhancing existing healthcare solutions or creating new offerings. This spending is vital for maintaining competitive advantage and innovation within the RCM and EHR markets. Higher investment levels typically signal a commitment to long-term product relevance and market leadership.